AKBA logo

Akebia Therapeutics, Inc. (AKBA) Cash From Investing

Annual CFI:

-$33.00K-$33.00K(-100.00%)
December 31, 2024

Summary

  • As of today, AKBA annual cash from investing is -$33.00 thousand, with the most recent change of -$33.00 thousand (-100.00%) on December 31, 2024.
  • During the last 3 years, AKBA annual cash from investing has fallen by -$39.97 million (-100.08%).
  • AKBA annual cash from investing is now -100.02% below its all-time high of $211.18 million, reached on December 31, 2019.

Performance

AKBA Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAcash flow metrics

Quarterly CFI:

-$126.00K-$280.00K(-181.82%)
June 1, 2025

Summary

  • As of today, AKBA quarterly cash from investing is -$126.00 thousand, with the most recent change of -$280.00 thousand (-181.82%) on June 1, 2025.
  • Over the past year, AKBA quarterly cash from investing has dropped by -$97.00 thousand (-334.48%).
  • AKBA quarterly cash from investing is now -100.11% below its all-time high of $110.47 million, reached on March 31, 2019.

Performance

AKBA Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAcash flow metrics

TTM CFI:

$24.00K-$97.00K(-80.17%)
June 1, 2025

Summary

  • As of today, AKBA TTM cash from investing is $24.00 thousand, with the most recent change of -$97.00 thousand (-80.17%) on June 1, 2025.
  • Over the past year, AKBA TTM cash from investing has increased by +$53.00 thousand (+182.76%).
  • AKBA TTM cash from investing is now -99.99% below its all-time high of $211.18 million, reached on December 31, 2019.

Performance

AKBA TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKBAcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

AKBA Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-100.0%-334.5%+182.8%
3Y3 Years-100.1%-100.0%+121.0%
5Y5 Years-100.0%+99.8%+100.0%

AKBA Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-100.1%+71.0%-181.8%at low-80.2%+121.0%
5Y5-Year-100.0%+99.9%-100.2%+99.8%-100.0%+100.0%
All-TimeAll-Time-100.0%+100.0%-100.1%+99.9%-100.0%+100.0%

AKBA Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$126.00K(-181.8%)
$24.00K(-80.2%)
Mar 2025
-
$154.00K(+7800.0%)
$121.00K(+466.7%)
Dec 2024
-$33.00K(>-9900.0%)
-$2000.00(0.0%)
-$33.00K(-6.5%)
Sep 2024
-
-$2000.00(+93.1%)
-$31.00K(-6.9%)
Jun 2024
-
-$29.00K(>-9900.0%)
-$29.00K(>-9900.0%)
Mar 2024
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2023
$0.00(+100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2023
-
$0.00(0.0%)
$0.00(+100.0%)
Dec 2022
-$114.00K(-100.3%)
$0.00(0.0%)
-$114.00K(0.0%)
Sep 2022
-
$0.00(0.0%)
-$114.00K(0.0%)
Jun 2022
-
$0.00(+100.0%)
-$114.00K(-100.6%)
Mar 2022
-
-$114.00K(>-9900.0%)
$19.89M(-50.2%)
Dec 2021
$39.94M(+199.8%)
$0.00(0.0%)
$39.94M(-59.9%)
Sep 2021
-
$0.00(-100.0%)
$99.62M(+100.5%)
Jun 2021
-
$20.00M(+0.3%)
$49.69M(+344.7%)
Mar 2021
-
$19.94M(-66.6%)
-$20.31M(+49.2%)
Dec 2020
-$40.00M(-118.9%)
$59.68M(+219.5%)
-$40.00M(+48.3%)
Sep 2020
-
-$49.94M(+0.1%)
-$77.41M(-2413.2%)
Jun 2020
-
-$49.99M(>-9900.0%)
-$3.08M(-103.1%)
Mar 2020
-
$245.00K(-98.9%)
$100.95M(-52.2%)
Dec 2019
$211.18M(+477.1%)
$22.28M(-8.7%)
$211.18M(+2.7%)
Sep 2019
-
$24.39M(-54.9%)
$205.61M(+7.0%)
Jun 2019
-
$54.03M(-51.1%)
$192.23M(+42.8%)
Mar 2019
-
$110.47M(+560.8%)
$134.63M(+267.9%)
DateAnnualQuarterlyTTM
Dec 2018
$36.59M(+120.6%)
$16.72M(+51.8%)
$36.59M(+216.3%)
Sep 2018
-
$11.01M(+408.6%)
$11.57M(+126.1%)
Jun 2018
-
-$3.57M(-128.7%)
-$44.40M(+38.8%)
Mar 2018
-
$12.43M(+249.7%)
-$72.52M(+59.1%)
Dec 2017
-$177.26M(-1495.2%)
-$8.31M(+81.5%)
-$177.26M(-20.9%)
Sep 2017
-
-$44.96M(-41.9%)
-$146.65M(-161.3%)
Jun 2017
-
-$31.69M(+65.7%)
-$56.12M(-1147.6%)
Mar 2017
-
-$92.30M(-513.8%)
$5.36M(-57.8%)
Dec 2016
$12.71M(+192.8%)
$22.31M(-51.0%)
$12.71M(+259.6%)
Sep 2016
-
$45.57M(+53.0%)
-$7.96M(+88.3%)
Jun 2016
-
$29.79M(+135.1%)
-$67.98M(+33.4%)
Mar 2016
-
-$84.95M(-5286.5%)
-$102.05M(-645.5%)
Dec 2015
-$13.69M(+79.1%)
$1.64M(+111.3%)
-$13.69M(+40.4%)
Sep 2015
-
-$14.46M(-238.0%)
-$22.96M(+52.7%)
Jun 2015
-
-$4.28M(-225.6%)
-$48.51M(+27.9%)
Mar 2015
-
$3.40M(+144.6%)
-$67.31M(-3.0%)
Dec 2014
-$65.35M(-472.0%)
-$7.64M(+80.9%)
-$65.35M(-16.7%)
Sep 2014
-
-$40.00M(-73.3%)
-$55.98M(-92.1%)
Jun 2014
-
-$23.07M(-530.7%)
-$29.14M(-380.4%)
Mar 2014
-
$5.36M(+208.8%)
-$6.07M(+46.9%)
Dec 2013
-$11.42M(-936.4%)
$1.74M(+113.2%)
-$11.42M(+13.2%)
Sep 2013
-
-$13.16M(>-9900.0%)
-$13.16M(>-9900.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00
$0.00
Dec 2012
$1.37M(+286.6%)
-
-
Dec 2011
-$732.10K
-
-

FAQ

  • What is Akebia Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Akebia Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Akebia Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Akebia Therapeutics, Inc.?
  • What is Akebia Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Akebia Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of AKBA is -$33.00K

What is the all-time high annual cash from investing for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high annual cash from investing is $211.18M

What is Akebia Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, AKBA annual cash from investing has changed by -$33.00K (-100.00%)

What is Akebia Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of AKBA is -$126.00K

What is the all-time high quarterly cash from investing for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high quarterly cash from investing is $110.47M

What is Akebia Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, AKBA quarterly cash from investing has changed by -$97.00K (-334.48%)

What is Akebia Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of AKBA is $24.00K

What is the all-time high TTM cash from investing for Akebia Therapeutics, Inc.?

Akebia Therapeutics, Inc. all-time high TTM cash from investing is $211.18M

What is Akebia Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, AKBA TTM cash from investing has changed by +$53.00K (+182.76%)
On this page